Dosing decisions include timing relationships (whether combined, separated, or coordinated) and individual compound doses to achieve synergistic NAD+ elevation
Many of these peptides, while showing immense promise in preclinical studies and anecdotal reports, lack the large-scale, rigorous human trials required by the FDA for formal approval
The bioactive compounds found in C
Currently, several senolytics were reported to kill senescent cells ( In this study, we tested the hypothesis that FOXO4-DRI treatment can selectively remove senescent cells in expanded human chondrocytes, thus enhancing their potential to generate high-quality cartilage
The goal is tolerability, not effect
Plasmid-based gene therapy with hepatocyte growth factor stimulates peripheral nerve regeneration after traumatic injury